APA (7th ed.) Citation

Merzon, E., Green, I., Vinker, S., Golan‐Cohen, A., Gorohovski, A., Avramovich, E., . . . Magen, E. (2021). The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection. The FEBS journal, 288(17), 5179-5189. https://doi.org/10.1111/febs.15784

Chicago Style (17th ed.) Citation

Merzon, Eugene, Ilan Green, Shlomo Vinker, Avivit Golan‐Cohen, Alessandro Gorohovski, Eva Avramovich, Milana Frenkel‐Morgenstern, and Eli Magen. "The Use of Aspirin for Primary Prevention of Cardiovascular Disease Is Associated with a Lower Likelihood of COVID‐19 Infection." The FEBS Journal 288, no. 17 (2021): 5179-5189. https://doi.org/10.1111/febs.15784.

MLA (9th ed.) Citation

Merzon, Eugene, et al. "The Use of Aspirin for Primary Prevention of Cardiovascular Disease Is Associated with a Lower Likelihood of COVID‐19 Infection." The FEBS Journal, vol. 288, no. 17, 2021, pp. 5179-5189, https://doi.org/10.1111/febs.15784.